ALLMedicine™ Liver Diseases Center
Research & Reviews 773 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867401
Journal of Hepatology; Cornberg M, Buti M et. al.
Feb 10th, 2021 - According to a recent World Health Organization estimate, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has spread globally, infecting nearly 100 million people worldwide by January 2...
https://doi.org/10.1007/s11095-021-02998-x 10.1016/j.cub.2017.09.019 10.1016/j.jhep.2019.01.030 10.1038/s41575-018-0009-6 10.1038/s41467-020-16092-0 10.1016/j.jhep.2005.10.013 10.1002/hep.21563 10.1200/JCO.2014.57.9151 10.1002/hep.29913 10.1002/bjs.10095 10.1016/j.jhep.2016.09.008 10.1111/j.1440-1746.2007.05175.x 10.1016/S0046-8177(98)90205-2 10.1111/liv.13174 10.1016/j.cca.2013.05.020 10.1152/ajprenal.90513.2008 10.1007/s11010-005-9047-9 10.1681/ASN.2007010097 10.1016/S0021-9258(19)74191-X 10.1186/s12906-016-1228-4 10.1016/j.jhep.2010.11.024 10.1016/j.transproceed.2004.12.103 10.1016/S0140-6736(19)31894-X 10.1002/hep.28945 10.1002/hep.29802 10.7150/ijms.40417 10.1007/s00508-014-0680-8 10.1016/j.arcmed.2012.11.007 10.1016/j.jhep.2014.10.039 10.1194/jlr.M020966 10.1002/hep.26318 10.1194/jlr.M077487 10.18632/oncotarget.7571 10.1002/hep4.1350
Pharmaceutical Research; Eguchi A, Iwasa M
Feb 3rd, 2021 - Liver-type fatty acid-binding protein (L-FABP) is mainly expressed in the liver as well as the proximal tubular epithelial cells in the kidney. In general, the proteins and enzymes existing within the hepatocytes have the potential to become bioma...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789069
World Journal of Gastroenterology; Ni XX, Lian M et. al.
Jan 28th, 2021 - Hepatic steatosis commonly occurs in some chronic liver diseases and may affect disease progression. To investigate the performance of controlled attenuation parameter (CAP) for the diagnosis of hepatic steatosis in patients with autoimmune liver ...
https://doi.org/10.1039/d0fo02457k
Food & Function; Shi J, Zhou X et. al.
Jan 26th, 2021 - Alcoholic liver diseases (ALDs) impose a substantial health burden on many countries. Bioactive peptides isolated from people, marine organisms, animals and plants have shown hepatoprotective effects on animal and hepatocyte models. In this study,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790257
PloS One; Cha HJ, Hwang J et. al.
Jan 7th, 2021 - We aimed to determine the significance of cytoplasmic antinuclear antibody (ANA) patterns using computer-aided immunofluorescence microscopy in patients with autoimmune liver diseases (AILD). ANA staining pattern was identified by treating culture...
Guidelines 7 results
https://doi.org/10.1016/j.clinre.2019.07.018
Clinics and Research in Hepatology and Gastroenterology; Antonini TM, Girard M et. al.
Sep 30th, 2019 - Transition describes a progressive and highly coordinated process encompassing the transfer of a young patient from paediatric care to the adult-care system. Transfer of medical care for an adolescent to adult services is a complex and challenging...
https://www.aasld.org/sites/default/files/guideline_documents/PracticeGuidelines-PBC-November2018.pdf
Oct 31st, 2018 - This American Association for the Study of Liver Diseases (AASLD) 2018 Practice Guidance on Primary Biliary Cholangitis (PBC) is an update of the PBC guidelines published in 2009. The 2018 updated guidance on PBC includes updates on etiology and d.
https://www.aasld.org/sites/default/files/PracticeGuidelines-HCV-November2018.pdf
AASLD-IDSA HCV Guidance Panel
Oct 29th, 2018 - Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-ba.
https://doi.org/10.1159/000368141
Oncology Kudo M, Matsui O et. al.
Nov 27th, 2014 - Surveillance and diagnostic algorithms for hepatocellular carcinoma (HCC) have already been described in guidelines published by the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver ...
https://doi.org/10.1148/rg.336125104
Radiographics : a Review Publication of the Radiological ... McEvoy SH, McCarthy CJ et. al.
Oct 10th, 2013 - Hepatocellular carcinoma is a malignancy that predominantly occurs in the setting of cirrhosis. Its incidence is rising worldwide. Hepatocellular carcinoma differs from most malignancies because it is commonly diagnosed on the basis of imaging fea...
Drugs 1 results see all →
Clinicaltrials.gov 865 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867401
Journal of Hepatology; Cornberg M, Buti M et. al.
Feb 10th, 2021 - According to a recent World Health Organization estimate, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has spread globally, infecting nearly 100 million people worldwide by January 2...
https://doi.org/10.1007/s11095-021-02998-x 10.1016/j.cub.2017.09.019 10.1016/j.jhep.2019.01.030 10.1038/s41575-018-0009-6 10.1038/s41467-020-16092-0 10.1016/j.jhep.2005.10.013 10.1002/hep.21563 10.1200/JCO.2014.57.9151 10.1002/hep.29913 10.1002/bjs.10095 10.1016/j.jhep.2016.09.008 10.1111/j.1440-1746.2007.05175.x 10.1016/S0046-8177(98)90205-2 10.1111/liv.13174 10.1016/j.cca.2013.05.020 10.1152/ajprenal.90513.2008 10.1007/s11010-005-9047-9 10.1681/ASN.2007010097 10.1016/S0021-9258(19)74191-X 10.1186/s12906-016-1228-4 10.1016/j.jhep.2010.11.024 10.1016/j.transproceed.2004.12.103 10.1016/S0140-6736(19)31894-X 10.1002/hep.28945 10.1002/hep.29802 10.7150/ijms.40417 10.1007/s00508-014-0680-8 10.1016/j.arcmed.2012.11.007 10.1016/j.jhep.2014.10.039 10.1194/jlr.M020966 10.1002/hep.26318 10.1194/jlr.M077487 10.18632/oncotarget.7571 10.1002/hep4.1350
Pharmaceutical Research; Eguchi A, Iwasa M
Feb 3rd, 2021 - Liver-type fatty acid-binding protein (L-FABP) is mainly expressed in the liver as well as the proximal tubular epithelial cells in the kidney. In general, the proteins and enzymes existing within the hepatocytes have the potential to become bioma...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789069
World Journal of Gastroenterology; Ni XX, Lian M et. al.
Jan 28th, 2021 - Hepatic steatosis commonly occurs in some chronic liver diseases and may affect disease progression. To investigate the performance of controlled attenuation parameter (CAP) for the diagnosis of hepatic steatosis in patients with autoimmune liver ...
https://doi.org/10.1039/d0fo02457k
Food & Function; Shi J, Zhou X et. al.
Jan 26th, 2021 - Alcoholic liver diseases (ALDs) impose a substantial health burden on many countries. Bioactive peptides isolated from people, marine organisms, animals and plants have shown hepatoprotective effects on animal and hepatocyte models. In this study,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790257
PloS One; Cha HJ, Hwang J et. al.
Jan 7th, 2021 - We aimed to determine the significance of cytoplasmic antinuclear antibody (ANA) patterns using computer-aided immunofluorescence microscopy in patients with autoimmune liver diseases (AILD). ANA staining pattern was identified by treating culture...
News 95 results
https://www.medscape.com/viewarticle/940855
Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...
https://www.medscape.com/viewarticle/940975
Nov 12th, 2020 - Almost 60% of patients with biopsy-confirmed nonalcoholic steatohepatitis and liver fibrosis showed resolution of NASH after treatment with semaglutide,according to a phase 2, double-blind, randomized, placebo-controlled trial published in the New...
https://www.staging.medscape.com/viewarticle/930411
May 13th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patien...
https://reference.staging.medscape.com/viewarticle/929475_6
May 10th, 2020 - Weight loss is a recommended treatment strategy for NASH. The American Association for the Study of Liver Diseases (AASLD) indicate that a 3%-5% weight loss reduces hepatic steatosis, but that up to a 10% weight loss might be needed to improve nec...
https://www.mdedge.com/gihepnews/article/220026/coronavirus-updates/aasld-liver-transplants-should-proceed-despite-covid-19?channel=63993
M. Alexander Otto, MDedge News
Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.